Meeting
2018 ASCO Quality Care Symposium
Can oral chemotherapy parity laws reduce patients’ out-of-pocket (OOP) costs?
Authors
Andrea Phillips Sitlinger
Duke University Medical Center, Durham, NC
Andrea Phillips Sitlinger, Peter A. Ubel, Tian Zhang, Charlene Wong, Rishi Sachdev, David Anderson, Yousuf Zafar
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Big Data Studies; Projects Relating to Equity, Value, and Policy
Track
Projects Relating to Equity, Value and Policy,Big Data Studies
Sub Track
Measuring Value and Costs
Citation
J Clin Oncol 36, 2018 (suppl 30; abstr 97)
DOI
10.1200/JCO.2018.36.30_suppl.97
Abstract #
97
Poster Bd #
K4
Abstract Disclosures
Similar Posters
Poster
2018 ASCO Annual Meeting
Can oral chemotherapy parity laws reduce patients’ out-of-pocket (OOP) costs?
First Author: Andrea Phillips Sitlinger
Poster
2023 ASCO Genitourinary Cancers Symposium
Utilization of metastatic hormone sensitive prostate cancer (mHSPC) treatment in a community oncology practice setting.
First Author: Terri Conner
Poster
2022 ASCO Annual Meeting
A phase 2 randomized study of oral docetaxel plus ritonavir (ModraDoc006/r) in patients with metastatic castration-resistant prostate cancer (mCRPC).
First Author: Ulka N. Vaishampayan
Poster
2017 Genitourinary Cancers Symposium
Early docetaxel-resistance in metastatic hormone-sensitive prostate cancer.
First Author: Nedal Bukhari